Markets
Bill Ackman
Bill Ackman (Sylvain Gaboury, Patrick McMullan/Getty Images)

Bill Ackman’s pricey IPO plan

Pershing Square’s fundraising efforts need to bear fruit for this valuation to make sense

Jack Raines

Bill Ackman made headlines this morning after The Wall Street Journal reported that he is planning to take his investment fund, Pershing Square, public in late 2025 or early 2026. As a precursor to the planned IPO, Ackman is also selling a stake in the firm to investors in a funding round that will value Pershing Square at approximately $10.5B.

It’s rare for a hedge fund to IPO in the US because the US Investment Company Act of 1940 prevents investing groups from charging retail investors expensive performance fees, such as the “2 and 20” that is common for hedge funds. Hedge funds can, however, charge “qualified purchasers” (generally high-net worth clients or institutions) higher fees, which is why hedge funds are typically private.

However, Bill Ackman isn’t looking to take a “hedge fund” public. To quote the Journal piece (emphasis ours):

Pershing Square has told potential investors to compare it to asset managers like Brookfield Asset Management and Blue Owl Capital rather than hedge funds. Brookfield’s market value is about $15 billion; it has more than $925 billion in assets under management. Blue Owl’s market value is about $28 billion and it manages more than $174 billion.

Basically, Ackman isn’t looking to take a specific investment vehicle public. He wants to IPO the holding company that happens to own several investment vehicles, which… kind of makes sense?

As of their February 2024 annual report, Pershing Square had $18.2B in assets under management (AUM), consisting of the following:

  • $14.6B in a closed-end Europe fund (PSH), which is listed on the Amsterdam and London exchanges

  • $1.6B in an investment vehicle that it used to purchase a stake of United Music Group

  • $2B in traditional hedge funds

Pershing listed its largest fund in the European markets in 2014 to skirt US regulations regarding fees: while they couldn’t charge high performance fees on a publicly traded US-listed fund, they can (and do) charge a 1.5% management fee and a 16% performance fee on their European fund.

The planned IPO would sell stakes in the parent entity controlling the funds, which wouldn’t charge high management fees, rather than a specific investment vehicle. While The Wall Street Journal reported that the $10.5B valuation looks high, (for context, Blue Owl Capital is worth $28B with $174B in AUM), the firm justified its valuation by explaining that it will soon manage much more money. From the Journal piece:

The firm justified its rich valuation to investors by explaining that it expects to manage considerably more money, and eventually earn more in fees, after Pershing Square U.S.A. and other funds launch, people familiar with the matter said.

In February, Ackman announced plans to launch a $10 billion US-based closed-end fund which, importantly, would not charge a performance fee, and just a flat 2% management fee, keeping it within US regulations. 

Additionally, Pershing also received SEC approval to raise a multi-billion dollar “special-purpose acquisition rights company,” or SPARC, to take a private company public, which would further increase its AUM.

Why is Ackman now prioritizing the American market after a decade with most of his firm’s capital in Europe? One reason is that Pershing’s Europe-listed fund is trading at a ~27% discount to its net asset value (NAV), meaning that the price per share of its fund is worth 27% less than the value of its underlying assets. If Pershing’s European fund traded at a premium to its NAV, Pershing could issue new shares and raise money until the price per share matched the underlying assets. With its share price at a discount, however, any capital raise in Europe would be below the fund’s intrinsic value.

While Pershing’s $10 billion valuation feels high for the firm right now, that number could look more reasonable in the future depending on the company’s ability to raise funds for its new US closed-end fund, its SPARC, and any other ventures that Ackman may have up his sleeve.

More Markets

See all Markets
markets
Nate Becker

Health insurance stocks lose steam as Trump says he’ll lobby insurers for lower prices

Shares of health insurance companies dropped Friday afternoon, as President Trump said he would ask insurers to meet with him in the coming weeks to seek lower prices.

Stocks including Humana, UnitedHealthcare, Cigna, CVS Health, and Elevance Health all either pared gains or went further into the red after Trump’s remarks, which came at the end of a press event to announce pricing deals with nine drugmakers.

“I’m going to call a meeting of the big insurance companies that have gotten so rich,” Trump said, noting that he would lobby them for lower prices.

“I would say that maybe with one talk, they would be willing to cut their prices by 50, 60, or 70%. They’ve made a fortune.”

markets

Rivian’s surge continues as stock reaches highest level since December 2023 on analyst upgrades

Shares of EV maker Rivian are on pace to close up double digits for the second day in a row on Friday as bullish investors pour into the stock following analyst upgrades.

Rivian shares were up more than 10% on Friday afternoon, with the stock climbing to its highest level since December 2023.

Webush’s Dan Ives boosted his Rivian price target by 56% to $25 in a note on Friday morning. The analyst wrote that 2026 is a “prove-me” year for the automaker, with its lower-cost R2 model set to launch in the first half.

Ives’s note follows a separate optimistic bit of analysis from Baird, which also boosted its Rivian price target to $25 in a note on Thursday.

If today's gains hold, Friday will mark the third day of double-digit gains for Rivian in the past six trading days. An “AI Day” event that saw the automaker detail autonomous updates and tease a robotaxi plan started the recent run.

markets
Luke Kawa

The neoclouds are shooting back up into the stratosphere

Investors’ faith in tech CEOs’ pursuit of digital God has seemingly been restored for now, sparking an intense rally in the speculative AI players that had been in full-on meltdown mode over concerns that the boom had passed its best-before date.

The data center companies colloquially known as the “neoclouds” — CoreWeave, Nebius, IREN, and Cipher Mining — are up more than double digits over the past two sessions, as of 10:40 a.m. ET.

The past 48 hours have brought a steady drumbeat of positive news for the AI theme.

CoreWeave received a vote of confidence from Wall Street as Citi resumed coverage with a buy rating and price target of $135. Oracle, the epicenter of AI credit concerns, has seen a reversal in its fortunes as it nears an acquisition of TikTok’s US operations. And OpenAI’s fundraising efforts appear be going so well that its reported valuation has gone up in back-to-back days.

Before that, Micron’s earnings reaffirmed the intense demand for AI compute, which continues to outstrip supply — a positive sign for the neoclouds. The macro backdrop is also turning perhaps a bit more in favor of lower interest rates, as CPI inflation came in well below expectations.

Snoop Dogg Performs At OVO Hydro Glasgow

Marijuana rescheduling could mean more investment in US weed stocks. There aren’t many ways in.

“Yes, institutional capital will go into the underlying names. The question is: How fast?" one weed company chairman said.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.